Hydrolysis of adenine nucleotides in platelets from patients with acute myocardial infarction

Clinical Biochemistry

Volumn 41, Issue 14-15, 2008, Pages 1181-1185

  Bagatini, Margarete D ^a   Martins, Caroline C ^a   Battisti, Vanessa ^a   Spanevello, Roselia M ^a   Gasparetto, Diogo ^b   Rosa, Cintia S ^a   Gonçalves, Jamile Fabrin ^a   Schetinger, Maria Rosa C ^a   dos Santos, Romualdo B ^b   Morsch, Vera Maria ^a  

^a Laboratorio de Sintese   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Acute myocardial infarction; Adenine nucleotides; Ischemia; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CLOPIDOGREL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; HYDROLYSIS; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADENINE NUCLEOTIDES; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ASPIRIN; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYDROLYSIS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TICLOPIDINE;

EID: 55649115761     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.07.008     Document Type: Article

References (35)

1. Hackam D.G., and Anand S.S. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 290 (2003) 932-940
2. Bhatt D.L., and Topol E.J. Need to test the arterial inflammation hypothesis. Circulation 106 (2002) 136-140
3. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
4. Ross R. Mechanisms of disease: atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
5. Pinsky D.J., Broekman M.J., Peschon J.J., et al. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 109 (2002) 1031-1040
6. Bakker W.W., Poelstra A., Barradas K., et al. Platelets and ectonucleotidases. Platelets 5 (1994) 121-129
7. Marcus A.J., Broekman M.J., Drosopoulos J.H.F., et al. Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). Thromb Haemost 1 (2003) 2497-2509
8. Marcus A.J., Broekman M.J., Drosopoulos J.H.F., et al. Heterologous cell-cell interactions:thromboregulation: inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular disease. Ital. Heart J 2 (2001) 824-830
9. Coade S.B., and Pearson J.D. Metabolism of adenine nucleotides in human blood. Circ Res 65 (1989) 531-537
10. Kunapuli S.P. Functional characterization of platelet ADP receptors. Platelets 9 (1998) 343-351
11. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 86 (2001) 222-232
12. Mahaut-Smith M.P., Ennion S.J., Rolf M.G., et al. ADP is not an agonist at P2X1 receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. Brit J Pharmacol 131 (2000) 108-114
13. 12 receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides. Mol Pharmacol 60 (2001) 416-420
14. Soslau G., and Youngprapakorn D. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochim Biophys Acta Mol Cell Res 1355 (1997) 131-140
15. Frassetto S.S., Dias R.D., and Sarkis J.J.F. Characterization of an ATP diphosphohydrolase activity (APYRASE, EC 3.6.1.5) in rat blood platelets. Mol Cell Biochem 129 (1993) 47-55
16. Ely S.W., and Berne R.M. Protective effects of adenosine in myocardial ischemia. Circulation 85 (1992) 893-904
17. Pilla C., Emanuelli T., Frasetto S.S., et al. ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets 7 (1996) 225-230
18. Lunkes G.L., Lunkes D., Stefanello F., et al. Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 109 (2003) 189-194
19. 2+-ATPase activity. Anal Biochem 157 (1986) 375-380
20. Richter T., Mürdter T.E., Heinkele G., et al. Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine. J Pharmacol Exp Ther 308 (2004) 189-197
21. Tendera M., and Wojakowski W. Role of antiplatelet drugs in the prevention of cardiovascular events. Thromb Res 110 (2003) 355-359
22. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 218-254
23. Burstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscl Throm 22 (2002) 364-372
24. Araújo M.C., Rocha J.B.T., Morsch A., et al. Enzymes that hydrolyze nucleotides in platelets from breast cancer patients. Biochem Biophys Acta 1740 (2005) 421-426
25. Silva A.C., Morsch A.L.B., Zanin R.F., et al. Enzymes that hydrolyzed adenine nucleotides in chronic renal failure: relationship between hemostatic defects and renal failure severity. Biochem Biophys Acta 1741 (2005) 282-288
26. Duarte M.M.F., Loro V.L., Rocha J.B.T., et al. Enzymes that hydrolyse adenine nucleotides of patients with hypercholesterolemia and inflammatory processes. FEBS J 274 (2007) 2707-2714
27. Zimmermann H. Ectonucleotidases: some recent developments and note on nomenclature. Drug Develop Res 52 (2001) 46-56
28. Robson S.C., Sévigny J., and Zimmermann H. The E-NTPDase family ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signalling 2 (2006) 409-430
29. Kittel A., Kiss A.L., Müllner N., Matkó I., and Sperlágh B. Expression of NTPDase 1 and caveolins in human cardiovascular disease. Histochem Cell Biol 124 (2005) 51-59
30. Rossatto E.R., Da Silva L.B., Pereira G.S., et al. ATP diphosphohydrolase in human platelets from patients with coronary arteries heart disease. Platelets 14 (2003) 47-52
31. Keeley E.C., and Hillis D. Primary PCI for myocardial infarction with ST-segment elevation. N Engl J Med 356 (2007) 47-54
32. Minamino T., Kitakaze M., Morioka T., et al. Cardioprotection due to preconditioning correlates with increased ecto-5′-nucleotidase activity. Am J Physiol 270 (1996) 238-244
33. Node K., Hasegawa M., Suzuki S., and Hori M. Induction of ecto-5'-nucleotidase contributes to the second-window of cardioprotection in ischemic preconditiong. Circulation 94 (1996) 1422
34. Pereillo J.M., Maftouh M., Andrieu A., et al. Structure and stereochemistry of the active metabolite of clopidogrel. Drug Metab Dispos 30 (2002) 1288-1295
35. Herbert J.M. Clopidogrel and antiplatelet therapy. Expert Opin Invest Drug 3 (1994) 449-455